Original ArticleIndian Journal of Pharmaceutical Education and ResearchVol. 56 | Issue 1 | 2022 | pp. 272–280Open access
Spectroscopic Substantiation for the Identification of Degradants by Q-TOF Micromass (ESI-MS) in Bisoprolol Fumarate with an Inventive Validation Approach for Stability Indicating HPLC Method
- 1,
- 2,
- 1*
- 1 Department of Pharmaceutical Analysis and Quality Assurance, Columbia Institute of Pharmacy, Raipur, Chhattisgarh, INDIA.
- 2 Department of Pharmacognosy, Columbia Institute of Pharmacy, Raipur, Chhattisgarh, INDIA.
Published in Indian Journal of Pharmaceutical Education and Research
Correspondence: Shiv Shankar Shukla
Department of Pharmaceutical Analysis and Quality Assurance, Columbia Institute of Pharmacy, Raipur, Chhattisgarh, INDIA.
Email: shivpharma007@gmail.com
Copyright: © 2022 Manuscript Technomedia. This is an open access article.
- Published:
- Jan 1, 2022
- Received:
- Apr 15, 2021
- Accepted:
- Dec 23, 2021
- DOI:
- 10.5530/ijper.56.1.32
How to cite
Pandey, S., Pandey, R., & Shukla, S. S. (2022). Spectroscopic Substantiation for the Identification of Degradants by Q-TOF Micromass (ESI-MS) in Bisoprolol Fumarate with an Inventive Validation Approach for Stability Indicating HPLC Method. Indian Journal of Pharmaceutical Education and Research, 56(1), 272–280. https://doi.org/10.5530/ijper.56.1.32
Abstract
Background: Stability studies, stress testing of drug substances and finished drug product is obligatory due to the guidelines by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) and other Regulatory Authorities. Materials and Methods: In the present work the selective Beta-1 receptor blocker, Bisoprolol fumarate was subjected to the forced degradation studies which includes hydrolysis (acidic, basic and neutral), oxidative, photolytic and thermal degradation. The drug was stable under light and basic and neutral medium. Results: The major findings in the presented work are the degradation products formed in the course of thermal degradation. The complete thermal degradation products were identified by High Performance Liquid Chromatography, Quadrupole-Time of Flight micromass (Electronspray Ionization-Mass Spectroscopy). The chromatographic conditions opted for the study includes Cosmosil C-18 column (4.6ID*250mm) with mobile phase consisting of methanol: phosphate buffer (pH 3.5 adjusted with orthophosphoric acid): Acetonitrile (45:35:20). Conclusion: The stability indicating method was validated as per the International Conference on Harmonization guidelines. The use of superior statistical tools for validation ensures the efficiency, quality and reproducibility of the presented method. Results obtained were agreeable and ensured the quality and reproducibility of the method.
Keywords
Subject
Article metadata
| Title | Spectroscopic Substantiation for the Identification of Degradants by Q-TOF Micromass (ESI-MS) in Bisoprolol Fumarate with an Inventive Validation Approach for Stability Indicating HPLC Method |
|---|---|
| Authors | Swati Pandey; Ravindra Pandey; Shiv Shankar Shukla |
| Affiliations | Department of Pharmaceutical Analysis and Quality Assurance, Columbia Institute of Pharmacy, Raipur, Chhattisgarh, INDIA.; Department of Pharmacognosy, Columbia Institute of Pharmacy, Raipur, Chhattisgarh, INDIA. |
| Corresponding author | shivpharma007@gmail.com |
| Journal | Indian Journal of Pharmaceutical Education and Research |
| Volume / Issue | Vol. 56, Issue 1 (2022) |
Also in this issue
- Development of Magnetic Nanoparticles and Encapsulation Methods – An Overviewpp. 1–8
- Telepharmacy Knowledge, Perceptions, and Readiness among Future Malaysian Pharmacists Amid the COVID-19 Pandemicpp. 9–16
- Perspectives of Pharmacy University Students on Scientific Research in Comparison to Students from Other Health Science Disciplinespp. 17–23
- New Approach of Dipterocarpus alatus Oil as a Permeation Enhancer in Ibuprofen Gelpp. 24–31
- Forced Degradation of Flibanserin Bulk Drug: Development and Validation of Stability Indicating RP-HPLC Methodpp. 32–42